Table 2.
OR | 95% CI | p-value | |
---|---|---|---|
Baseline characteristics | |||
Age | 1.10 | (1.03, 1.17) | 0.005 |
African American | 1.62 | (0.76, 3.46) | 0.21 |
History of major depressive disorder | 4.51 | (2.20, 9.25) | <.0001 |
Annual measures | |||
Menopausal status (referent category: premenopause) | |||
Perimenopause | 2.17 | (1.23, 3.81) | 0.007 |
Postmenopause | 3.43 | (1.79, 6.56) | <.0001 |
Hormone therapy use | 1.20 | (0.38, 3.73) | 0.76 |
Vasomotor symptoms ≥6days/past 2 weeks (hot flashes or night sweats) | 2.50 | (1.48, 4.22) | 0.001 |
BMI | 1.08 | (1.02, 1.13) | 0.004 |
Log E2** | 0.82 | (0.63, 1.06) | 0.13 |
Log T** | 1.04 | (0.62, 1.74) | 0.90 |
Log FSH** | 1.25 | (.97, 1.62) | 0.08 |
Change in E2 from baseline* | 1.00 | (1.00, 1.00) | 0.57 |
Change in Testosterone from baseline* | 1.01 | (1.00, 1.03) | 0.10 |
Change in FSH from baseline* | 1.00 | (0.99, 1.01) | 0.90 |
Adjusted for baseline value
Note: The results for hormones were similar when adjusted for BMI.